Effects of SK&F 93479 on experimentally induced ventricular arrhythmias in dogs, rats and mice
The effects of SK&F 93479, a potent histamine H2-receptor antagonist, on ventricular arrhythmias induced by coronary artery ligation in dogs and rats, and by aconitine infusion in mice were investigated. It was found that SK&F 93479 in large doses, significantly prevented the occurrence of spontaneous ventricular fibrillation and the changes in ventricular fibrillation threshold following coronary artery ligation in dogs. In rats subjected to ligation of the main left coronary artery, it significantly reduced the incidence of ventricular fibrillation, and significantly prolonged the time of onset of ventricular tachycardia and ventricular fibrillation. On the contrary, SK&F 93479 did not significantly alter the incidence or the time of onset of cardiac dysrhythmias caused by aconitine infusion in mice. These findings suggest that SK&F 93479 lacks non-specific antiarrhythmic activity and that its protective effects against coronary artery ligation may be mediated by its histamine H2-receptor antagonizing action. They also support the hypothesis that histamine may contribute to the genesis of ventricular arrhythmias resulting from acute myocardial ischaemia.
KeywordsCoronary Artery Protective Effect Histamine Myocardial Ischaemia Ventricular Tachycardia
Unable to display preview. Download preview PDF.
- A.S. Harris,Delayed development of ventricular ectopic rhythms following experimental coronary occlusion, Circulation1, 1318–1328 (1950).Google Scholar
- M. Hirata, K. Kikuchi andK. Hashimoto,Disappearance of ventricular arrhythmia caused by coronary occlusion during retrograde bleeding through collaterals, Jap. Circul. J.34, 531–537 (1970).Google Scholar
- R.A. Riemersma, Myocardial catecholamine release in acute mycocardial ischaemia; relationship to cardiac arrhythmias. InEarly Arrhythmias Resulting from Myocardial Ischaemia, pp. 125–138 (Ed.J.A. Parratt). Macmillan, New York 1982.Google Scholar
- S.J. Coker, Early ventricular arrhythmias arsing from acute myocardial ischaemia; possible involvement of prostaglandins and thromboxanes. InEarly Arrhythmias Resulting from Myocardial Ischaemia, pp. 219–237 (Ed.J.A. Parratt). Macmillan, New York 1982.Google Scholar
- R.W. Gristwood, J.C.R. Lincoln, D.A.A. Owen andI.R. Smith,Histamine release from human right atrium, Br. J. Pharmac.74, 7–9 (1981).Google Scholar
- G.V. Anrep, G.S. Barsoum andM. Talaat,Liberation of histamine by the heart muscle, J. Physiol., Lond.86, 431–451 (1936).Google Scholar
- J.P. Trzeciakowski andR. Levi,Reduction of ventricular fibrillation threshold by histamine: resolution into separate H 1 - and H 2 -mediated components, J. Pharmac. exp. Ther.223, 774–783 (1982).Google Scholar
- V.B. Fiedler, S. Schneider andR-E. Nitz,Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anaesthetized dogs, Pharmacology25, 96–101 (1982).Google Scholar
- C. Clark, M.I. Foreman, K.A. Kane, F.M. McDonald andJ.R. Parratt,Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J. Pharmac. Methods3, 357–368 (1980).Google Scholar
- P. U. Nwangwu, T.L. Holcslaw andS.J. Stohs,A rapid in vivotechnique for preliminary screening of antiarrhythmic agents in mice, Archs int. Pharmacodyn.229, 219–226 (1977).Google Scholar
- N.K. Dadkar andB.K. Bhattacharya,A rapid screening procedure for antiarrhythmic activity in the mouse. Archs int. Pharmacodyn.212, 297–301 (1974).Google Scholar
- R.C. Blakemore, T.H. Brown, G.J. Durant, C. R. Ganellin, M.E. Parsons, A.C. Rasmussen andD.A. Rawlings,SK&F 93479, a potent and long acting histamine H 2 -receptor antagonist, Br. J. Pharmac.74, 200p (1981).Google Scholar